Tag: Orphan drugs

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Orphan drugs

Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG

Added to Collection on: 2024-04-15 20:56:51

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Autoimmune diseases
Eculizumab
Myasthenia gravis
Rare diseases
Ravulizumab
Apheresis
Atypical hemolytic uremic syndrome

Click the tags to see associated articles and topics

View Article Details
Dr. Goswami's Oncology Journey: Patient-centric Science and Mentorship Stories - OncLive

Added to Collection on: 2024-04-15 19:20:50

Tags for this article:

Orphan drugs
Piperazines
Fluoroarenes
Pyridines
Antineoplastic drugs
Cetuximab
KRAS
Bevacizumab
Regorafenib
Adagrasib
Ponatinib
Radiation therapy

Click the tags to see associated articles and topics

View Article Details
Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run

Added to Collection on: 2024-04-16 12:41:10

Tags for this article:

Pritumumab
Forward-looking statement
Monoclonal antibodies
Orphan drugs
Sean Carrick
Nascent Biotech Inc.

Click the tags to see associated articles and topics

View Article Details
PF-08046054 by Pfizer for Non-Small Cell Lung Cancer: Likelihood of Approval

Added to Collection on: 2024-04-20 08:09:09

Tags for this article:

Antineoplastic drugs
Orphan drugs
Lung cancer
Antibody-drug conjugate
Biotechnology
Immunology
Clinical trial
Pfizer
Non-small-cell lung cancer
Cancer

Click the tags to see associated articles and topics

View Article Details
Safety Considerations for Ravulizumab in NMOSD: Sean Pittock, MD - NeurologyLive

Added to Collection on: 2024-04-23 19:08:11

Tags for this article:

Monoclonal antibodies
Orphan drugs
Autoimmune diseases
Rare diseases
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Multiple sclerosis
Aquaporin-4
Ravulizumab
Therapy

Click the tags to see associated articles and topics

View Article Details
Chronic Myelogenous Leukemia (CML): 5 Things to Know - Medscape

Added to Collection on: 2024-04-23 21:27:36

Tags for this article:

Orphan drugs
Piperazines
Chronic myeloid leukemia
Cancer treatments
Stem cells
Chronic myelogenous leukemia
Philadelphia chromosome
Leukemia
Dasatinib
Tumors of the hematopoietic and lymphoid tissues
Nilotinib
Imatinib
Philadelphia

Click the tags to see associated articles and topics

View Article Details
Drug Update: First Person Dosed with Investigational Therapy AlloNK for Lupus Nephritis

Added to Collection on: 2024-04-23 16:56:11

Tags for this article:

Immune system
Orphan drugs
Autoimmune diseases
Kidney diseases
Lymphocytes
Rituximab
Lupus
Natural killer cell
Obinutuzumab
CAR T cell
Sjögren syndrome
Nephritis

Click the tags to see associated articles and topics

View Article Details
Yale Urology Research [Q1: January-March 2024]

Added to Collection on: 2024-04-24 17:32:02

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Carcinoma
Transitional cell carcinoma
Pembrolizumab
Nivolumab
Checkpoint inhibitor
Renal cell carcinoma
Avelumab
Cora Sternberg
Draft:Alba Kihn Alarcón

Click the tags to see associated articles and topics

View Article Details
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of ...

Added to Collection on: 2024-04-24 15:38:29

Tags for this article:

Immune system
Lung cancer
Orphan drugs
Tyrosine kinase receptors
Cancer immunotherapy
Atezolizumab
Cancer immunology
Epidermal growth factor receptor
Natural killer cell
Non-small-cell lung cancer
Checkpoint inhibitor
Matuzumab
Germany
Mannheim

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Lynparza to dominate PARP inhibitors market with $4 billion in sales by 2027 ...

Added to Collection on: 2024-04-24 13:11:58

Tags for this article:

PARP inhibitors
Orphan drugs
Fluoroarenes
Lactams
Olaparib
Cancer treatment
PARP1
Breast cancer
Niraparib
AstraZeneca
Prostate cancer
Targeted therapy

Click the tags to see associated articles and topics

View Article Details